Cardiac Magnetic Resonance Predictors of Outcome of Rhythm Control in Patients with Atrial Fibrillation/Flutter
NCT ID: NCT06758895
Last Updated: 2025-01-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
90 participants
OBSERVATIONAL
2025-01-31
2026-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cardiovascular Magnetic Resonance-Guided Radiofrequency-Ablation for Atrial Flutter II
NCT03078985
Cardiovascular Magnetic Resonance-Guided Radiofrequency-Ablation for Atrial Flutter
NCT02699034
Atrial Fibrillation/Sinus Rhythm Before and After Cardioversion
NCT01779674
Demographic Outcomes, and Health Care Resources in Newly Diagnosed Non Valvular AF Patients
NCT04110197
Remote Magnetic Navigation For Cavotricuspid Isthmus Ablation
NCT00560872
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Reported antiarrhythmic drug efficacy to restore \& maintain sinus rhythm is 52% which is far from optimal.
* On the other hand, 5-year arrhythmia-free survival after catheter ablation was previously reported to be 63%.
* Therefore, there is a need for better characterization of the underlying atrial substrate, to improve treatment outcomes in terms of efficacy and safety
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients undergoing successful cardioversion (pharmacologic or electric) for atrial fibrillation/flutter, OR symptomatic patients with paroxysmal atrial fibrillation/flutter scheduled for trans-catheter ablation.
* Index cardioversion OR Index ablation procedure.
Exclusion Criteria
* Contraindications to CMR.
* Contraindications to Gd-based contrast.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maryam Ashraf Abd El-Naeem Sayed
Resident Doctor at Assiut University Heart Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Salah EL-dein Sayed Ata, Professor of cardiology
Role: STUDY_DIRECTOR
Assiut University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assiut Univeristy Heart Hospital
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
1. Calkins H et al. Circ Arrhythm Electrophysiol. 2009
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CMR in rythm control
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.